Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. May 21, 2009; 15(19): 2367-2371
Published online May 21, 2009. doi: 10.3748/wjg.15.2367
Published online May 21, 2009. doi: 10.3748/wjg.15.2367
Table 1 Demographic and clinical data (n = 29)
| Clinical parameter | n(%) or mean ± SD |
| Age | |
| mean ± SD (yr) | 64.5 ± 16.8 |
| Range | 24-86 |
| Sex | |
| Men | 13 (44.8) |
| Women | 16 (55.2) |
| Main indication for ERC | |
| Cholestasis/jaundice | 16 (55.2) |
| Choledocholithiasis/dilated CBD | 5 (17.2) |
| Cholangitis | 3 (10.3) |
| SOL of papilla | 3 (10.3) |
| Unresolved pancreatitis | 2 (6.9) |
| Abdominal ultrasound results | |
| Dilated CBD | 15 (51.7) |
| Cholelithiasis | 12 (41.4) |
| Dilated intrahepatic ducts | 10 (34.5) |
| Choledocholithiasis | 3 (10.3) |
| Pancreatitis | 1 (3.4) |
| CBD width (mm) | |
| mean ± SD | 8.7 ± 3.7 |
| Range | 6-18 |
| Liver function tests, mean ± SD (range) | |
| Total bilirubin (mg/dL) | 4.5 ± 6.9 (0.3-32) |
| Direct bilirubin (mg/dL) | 3.0 ± 4.9 (0.1-23) |
| Alanine aminotransferase (U/L) | 206.5 ± 243.3 (12-895) |
| Aspartate aminotransferase (U/L) | 156.4 ± 185.6 (15-812) |
| Gamma glutamyl transpeptidase (U/L) | 369.4 ± 370.4 (13-1337) |
| Alkaline phosphatase (U/L) | 291.0 ± 371.4 (56-1893) |
Table 2 Results of ERC (n = 29)
| Clinical parameter | n(%) or mean ± SD |
| Diagnosis | |
| CBD width (mm) | 9.4 ± 4.0 |
| Range | 6-18 |
| Choledocholithiasis | 11 (37.9) |
| Pigmented stones | 4 (13.8) |
| Cholelithiasis | 5 (17.2) |
| Enlarged papilla | 7 (24.1) |
| Dilated CBD | 15 (51.7) |
| CBD stricture | 4 (13.8) |
| Intrahepatic ducts dilation & stricture | 3 (10.3) |
| Torn papilla | 3 (10.3) |
| Bile leakage | 1 (3.4) |
| Mirizzi syndrome | 1 (3.4) |
| Treatment | |
| Sphincterotomy | 16 (55.2) |
| Biopsy of the papilla | 5 (17.2) |
| Stent insertion | 2 (6.9) |
| Cholecystostomy | 1 (3.4) |
Table 3 Mucin gene expression in bile collected in ERC
| Mucin gene | Score mean ± SD (range) | Cases (%) |
| MUC1 | 0.62 ± 0.94 (0-3) | 34.4 |
| MUC2 | 0.58 ± 0.90 (0-3) | 34.4 |
| MUC3 | 0.79 ± 0.97 (0-3) | 51.7 |
| MUC5AC | 1.06 ± 1.22 (0-3) | 51.7 |
| MUC5B | 1.20 ± 1.26 (0-3) | 55.1 |
| MUC6 | 0.41 ± 0.73 (0-2) | 27.5 |
Table 4 Correlation between the expression of the different mucin genes in bile collected by ERC
| Mucin gene | Correlation with mucin gene | Pvalue |
| MUC1 | MUC2 | 0.0001 |
| MUC3 | 0.0001 | |
| MUC5AC | 0.0125 | |
| MUC5B | 0.049 | |
| MUC6 | 0.0001 | |
| MUC2 | MUC3 | 0.0001 |
| MUC5AC | 0.0080 | |
| MUC5B | 0.0001 | |
| MUC6 | 0.0001 | |
| MUC3 | MUC5AC | 0.0031 |
| MUC6 | 0.0003 |
Table 5 Comparison between patients with (n = 17) and without (n = 12) gallstones
| Gallstones diseas n (%) | No evidence for gallstones n (%) | Pvalue | |
| Age, mean ± SD (years) | 61.35 ± 20.13 | 69.00 ± 9.58 | 0.234 |
| Sex (men) | 8 (47.1) | 5 (41.7) | 0.927 |
| Main indication for ERC | |||
| Jaundice | 7 (41.1) | 9 (75) | 0.153 |
| Dilated CBD | 4 (23.5) | 1 (8.0) | 0.554 |
| Cholangitis | 3 (20.0) | 0 | 0.288 |
| SOL of papilla | 1 (6.0) | 2 (17.0) | 0.737 |
| Unresolved pancreatitis | 2 (12.0) | 0 | 0.288 |
| Abdominal ultrasound results | |||
| Dilated CBD | 10 (59.0) | 5 (42) | 0.599 |
| Cholelithiasis | 12 (70.6) | 0 | < 0.0001 |
| Dilated intrahepatic ducts | 6 (40) | 4 (30) | 0.873 |
| Choledocholithiasis | 3 (17.6) | 0 | 0.360 |
| Pancreatitis | 1 (5.9) | 0 | 0.861 |
| CBD width (mm), mean ± SD | 9.65 ± 4.39 | 7.50 ± 2.24 | 0.132 |
| Liver function tests, mean ± SD | |||
| Total bilirubin (mg/dL) | 5.12 ± 7.83 | 3.68 ± 5.52 | 0.589 |
| Direct bilirubin (mg/dL) | 3.38 ± 5.53 | 2.55 ± 4.03 | 0.662 |
| Alanine aminotransferase (U/L) | 245.41 ± 270.76 | 151.58 ± 196.14 | 0.315 |
| Aspartate aminotransferase (U/L) | 167.29 ± 150.54 | 141.08 ± 233.11 | 0.715 |
| Gamma glutamyl transpeptidase (U/L) | 443.47 ± 388.13 | 264.50 ± 331.14 | 0.206 |
| Alkaline phosphatase (U/L) | 352.88 ± 449.95 | 185.08 ± 174.44 | 0.323 |
| ERC diagnosis | |||
| CBD width (mm), mean ± SD | 9.59 ± 3.99 | 9.17 ± 4.37 | 0.790 |
| Choledocholithiasis | 11 (64.7) | 0 | 0.002 |
| Pigmented stones | 4 (24.0) | 0 | 0.198 |
| Cholelithiasis | 5 (29.0) | 0 | 0.122 |
| Enlarged papilla | 3 (16.0) | 4 (33.0) | 0.533 |
| Dilated CBD | 10 (60.0) | 5 (40.0) | 0.494 |
| CBD stricture | 1 (10.0) | 3 (30.0) | 0.376 |
| Torn papilla | 3 (17.6) | 0 | 0.360 |
| Treatment | |||
| Sphincterotomy | 12 (71.0) | 4 (33.0) | 0.099 |
| Biopsy of the papilla | 1 (10.0) | 4 (33.0) | 0.288 |
| Mucin gene score, mean ± SD | |||
| Mucin concentration (mg/mL) | 21.68 ± 7.87 | 24.54 ± 24.1 | 0.759 |
| Protein concentration (mg/mL) | 7.87 ± 4.53 | 8.61 ± 5.48 | 0.694 |
| MUC1 | 0.59 ± 0.87 | 0.66 ± 1.07 | 0.848 |
| MUC2 | 0.53 ± 0.80 | 0.66 ± 1.07 | 0.711 |
| MUC3 | 0.88 ± 0.93 | 0.66 ± 1.07 | 0.560 |
| MUC5AC | 0.47 ± 0.80 | 0.33 ± 0.65 | 0.621 |
| MUC5B | 1.23 ± 1.25 | 0.83 ± 1.19 | 0.394 |
| MUC6 | 1.29 ± 1.26 | 1.08 ± 1.31 | 0.667 |
- Citation: Vilkin A, Geller A, Levi Z, Niv Y. Mucin gene expression in bile of patients with and without gallstone disease, collected by endoscopic retrograde cholangiography. World J Gastroenterol 2009; 15(19): 2367-2371
- URL: https://www.wjgnet.com/1007-9327/full/v15/i19/2367.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2367
